Pharma brands earned 9.2 percent of top Google rankings but just 4.2 percent of AI Overview citations, according to a Search Engine Land analysis published November 18, 2026. The gap between ranking and citation is the story: a brand can dominate the classic results and still be nearly invisible inside the AI answers that sit above them.
Matt Lowe's analysis for Search Engine Land found that pharma brands earned 9.2 percent of top Google rankings but only 4.2 percent of AI Overview citations. The two numbers measure different things: rankings measure where a page appears in the classic results, while citations measure how often the AI Overview draws on a page as a source.
The gap is more than two to one. For every hundred top rankings pharma brands hold, they get fewer than half as many citations. That means the AI Overviews are sourcing their answers from somewhere else, and the brands that win the rankings race are losing the citation race.
AI Overviews do not cite the top-ranked page by default. They cite the pages whose content best answers the question in a quotable form, and those are often not the pages that rank first. A pharma brand page that ranks well because of authority and links may still lose the citation to a page that answers the question more directly.
The pharma vertical makes the gap worse. Drug information is heavily regulated, so brand pages are often cautious, general, and hedged. AI Overviews prefer specific, direct answers, which means they often cite patient resources, medical references, or condition guides instead of the brand's own page.
For SEOs, the pharma gap is a warning that ranking and citation are diverging metrics. A strategy that optimizes only for rankings can succeed on its own terms and still fail in the AI layer. Teams need to track citations as a separate outcome, as Kevin Indig's meta-analysis argued the same day.
For link builders, the gap is an opening. The pages that win citations are the pages that answer questions well, and those pages earn links too. A content program that builds citation-worthy pages is building link-worthy pages at the same time. The two goals have converged, and pharma is the clearest proof.
Watch whether the gap narrows or widens as AI Overviews expand. If Google's citation selection starts to favor authoritative brand pages more, the gap will close. If it keeps favoring direct answers, the gap will persist, and pharma brands will need a different content strategy for the AI layer.
Watch also for the same analysis in other verticals. Pharma is a regulated, cautious vertical, so the gap may be largest there. But if similar gaps show up in finance, insurance, or legal, the lesson becomes general: ranking is no longer enough, and citation is a separate game.
Pharma brands that want to close the citation gap need to publish content that answers questions directly, which is harder than it sounds in a regulated industry. Drug information pages are written by lawyers as much as by doctors, and the result is often cautious and general. An AI Overview looking for a direct answer will skip the cautious page and cite a patient resource or a medical reference instead.
The fix is not to abandon caution, but to add clarity alongside it. A page that states the answer plainly and then explains the caveats is citable and compliant at the same time. The brands that learn to write that way will win citations; the brands that keep publishing hedged generalities will keep winning rankings and losing the AI layer.
Sources: Search Engine Land, November 18, 2026.
Related reading on this site: AI Overviews Showed Up in Only 20% of Local Searches, and Mostly Copied the Map Pack, ChatGPT Wallet Lets AI Agents Pay Without Seeing Your Card Number, November 2026 Core Update Still Rolling Out as Volatility Peaks on November 14, Domain Authority Barely Correlates With AI Citations, Search Atlas Finds, Social Networks Are a Minor AI Search Source — Except LinkedIn and YouTube, and Semrush Rebuilds Traffic and Market Data With a New Model, and Old Numbers Will Change.
Linkbaits helps you create content that earns citations and backlinks. Start with the toolkit and build your first linkable asset this week.
Start free trial